NC Company Raises Millions to Fight Cancer

  RESEARCH TRIANGLE PARK – G1 Therapeutics (Nasdaq: GTHX) is rolling out clinical trials for…

Continue Reading ›

Are You Screening Your Patients for Lung Cancer?

    According to NCDHHS, it is estimated that 9,247 people in North Carolina will be…

Continue Reading ›

Blood Cancer Drug Fails Main Goal of Trial

GlaxoSmithKline (GSK) recently announced that their blood cancer drug Blenrep failed the main goal…

Continue Reading ›

It’s Movember! UNC School of Medicine, Others Promoting No-Shave November

Folks, put away those razors. No-Shave November is here. Started in Australia in 2003, Movember —…

Continue Reading ›

Could A Single Blood Test Screen for Most Common Cancer Types?

  What if a single blood test could screen for most common cancer types all at once?…

Continue Reading ›

Could Drug-Resistant Fungi Pose a Significant Public Health Threat to NC?

Recently, the World Health Organization (WHO) released its first-ever list of fungal "priority…

Continue Reading ›

FDA Plans New Mammogram Regulations

  Mammograms can sometimes fail to detect tumors in women who have a higher breast density.…

Continue Reading ›

On Point: Colonoscopy Remains The Best Method To Prevent Colon Cancer – Several Doctors Respond to New Study

On Point submissions are individual member viewpoints and not North Carolina Medical Society…

Continue Reading ›

Are Colonoscopies Really Effective? New Research Suggests the Value May Be Overestimated

According to new research, colonoscopies may not be as effective at preventing and reducing the…

Continue Reading ›

No One Fights Alone! NCMS Staff Show Support for Breast Cancer Awareness Month

RALEIGH — The staff of the North Carolina Medical Society are…

Continue Reading ›